U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6456164561Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal DiseaseRecruitingNo Results AvailableEnd Stage Renal DiseaseOther: extended treatment time|Other: Standard treatment timehttps://ClinicalTrials.gov/show/NCT01721421
6456264562A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal InfectionRecruitingNo Results AvailableIntra-abdominal InfectionDrug: Tigecycline|Drug: Imipenem/cilastatinhttps://ClinicalTrials.gov/show/NCT01721408
6456364563Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their ParentsCompletedNo Results AvailableCoughDietary Supplement: Agave Syruphttps://ClinicalTrials.gov/show/NCT01721395
6456464564Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic FibrosisRecruitingNo Results AvailableCystic FibrosisDrug: Sitagliptinhttps://ClinicalTrials.gov/show/NCT01721382
6456564565Syncope in Cataluña SYNCATCompletedNo Results AvailableBrief Loss of Consciousnesshttps://ClinicalTrials.gov/show/NCT01721369
6456664566Neurobiological Basis of Emotional IntelligenceCompletedNo Results AvailableEmotional Intelligencehttps://ClinicalTrials.gov/show/NCT01721356
6456764567Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV CancerRecruitingNo Results AvailableCognitive/Functional Effects|Malignant Neoplasm|PainBehavioral: telephone-based intervention|Other: case management|Procedure: management of therapy complications|Procedure: physical therapy|Other: questionnaire administration|Procedure: quality-of-life assessment|Procedure: management of therapy complications|Procedure: assessment of therapy complications|Other: educational intervention|Procedure: management of therapy complications|Procedure: assessment of therapy complications|Procedure: assessment of therapy complicationshttps://ClinicalTrials.gov/show/NCT01721343
6456864568A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity DisorderTerminatedNo Results AvailableADHD|Attention Deficit Hyperactivity DisorderDrug: Naltrexone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01721330
6456964569Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset SeizuresTerminatedHas ResultsSeizuresDrug: Ezogabine/Retigabine IR|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01721317
6457064570Decisionmaking for Abnormal Uterine Bleeding (AUB)CompletedNo Results AvailableAbnormal Uterine BleedingOther: Adaptive Conjoint Analysishttps://ClinicalTrials.gov/show/NCT01721304
6457164571Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)Active, not recruitingNo Results AvailableCHRONIC OBSTRUCTIVE PULMONARY DISEASE|ASTHMA|HEALTHY SUBJECTSDrug: SALBUTAMOLhttps://ClinicalTrials.gov/show/NCT01721291
6457264572Furlong Evolution® Hip TrialNot yet recruitingNo Results AvailableFocus: A Multicentre Prospective Clinical Surveillance Study Aims to Assess the Clinical, Functional and Radiological Outcome of the Furlong Evolution® Hip Stemhttps://ClinicalTrials.gov/show/NCT01721278
64573645733-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting AntiviralsTerminatedNo Results AvailableHepatitis Chttps://ClinicalTrials.gov/show/NCT01721265
6457464574Tarceva. ICORG 08-41CompletedNo Results AvailableNon-small Cell Lung Cancerhttps://ClinicalTrials.gov/show/NCT01721252
6457564575Recovery and Aftercare in Post Intensive Care Therapy Patients - RAPIT StudyActive, not recruitingNo Results AvailableIntensive Care (ICU) PatientsOther: Standardized Followup programhttps://ClinicalTrials.gov/show/NCT01721239
6457664576CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)RecruitingNo Results AvailableHuman Immunodeficiency VirusDevice: Intervention Arm (computer-based CARE+ Corrections tool)|Other: Educational video on opiate overdose preventionhttps://ClinicalTrials.gov/show/NCT01721226
6457764577Trobaltâ„¢ Products Risk SurveyCompletedNo Results AvailableEpilepsyDrug: Trobaltâ„¢https://ClinicalTrials.gov/show/NCT01721213
6457864578"Learning About Biologics"-Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisOther: Decision Support Tool|Other: Usual Carehttps://ClinicalTrials.gov/show/NCT01721200
6457964579Satiety Effects on the Neural Valuation of FoodCompletedNo Results AvailableFasting|Fedhttps://ClinicalTrials.gov/show/NCT01721187
6458064580Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct StricturesRecruitingNo Results AvailablePancreatic Cancer|CholangiocarcinomaProcedure: SEMS only|Procedure: EBRFA and SEMShttps://ClinicalTrials.gov/show/NCT01721174
6458164581215ON201 BIIB033 In Acute Optic Neuritis (AON)CompletedNo Results AvailableAcute Optic NeuritisBiological: BIIB033 (anti-LINGO-1 mAb)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01721161
6458264582A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid TumoursActive, not recruitingNo Results AvailableMalignant Solid TumourDrug: ASLAN002( BMS 777607)https://ClinicalTrials.gov/show/NCT01721148
6458364583A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.WithdrawnNo Results AvailableAsthmaDrug: GSK2190915 100mg|Drug: GSK2190915 200mg|Drug: moxifloxacin 400mg|Drug: moxifloxacin placebo|Drug: GSK2190915 placebohttps://ClinicalTrials.gov/show/NCT01721135
6458464584[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01721122
6458564585Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in AdolescentsActive, not recruitingNo Results AvailableAcquired Immunodeficiency Syndrome|HIV InfectionsDrug: EVG/COBI/FTC/TDFhttps://ClinicalTrials.gov/show/NCT01721109
6458664586XIENCE PRIME Japan Post-Marketing Surveillance (PMS)Active, not recruitingNo Results AvailableAngina|Coronary Occlusion|Coronary Artery Disease|Coronary Artery Stenosis|Myocardial IschemiaDevice: XIENCE PRIME - Long Length (LL)|Device: XIENCE PRIME - Core Lengthhttps://ClinicalTrials.gov/show/NCT01721096
6458764587Comparison of Two Methods of Immunization for Intramuscular InjectionsCompletedNo Results AvailableConsequences of Immunization MethodProcedure: Procedure: Z-track|Procedure: Procedure: Bunchhttps://ClinicalTrials.gov/show/NCT01721083
6458864588Effect of Ketoconazole on Sufentanil NanoTab PharmacokineticsCompletedHas ResultsPharmacokineticsDrug: Sufentanil NanoTab (SUF NT) 15 mcg|Drug: Ketoconazole 400 mg, sufentanil NanoTab (SUF NT) 15 mcghttps://ClinicalTrials.gov/show/NCT01721070
6458964589A Study in Moderate to Severe Rheumatoid Arthritis ParticipantsCompletedNo Results AvailableRheumatoid ArthritisDrug: Placebo|Drug: Baricitinibhttps://ClinicalTrials.gov/show/NCT01721057
6459064590A Moderate to Severe Rheumatoid Arthritis StudyCompletedNo Results AvailableRheumatoid ArthritisDrug: Placebo|Drug: Baricitinibhttps://ClinicalTrials.gov/show/NCT01721044

* Görseller ve İçerik tekif hakkına sahip olabilir